The market growth is driven by an increasing There is a growing emphasis on adopting sustainable and ethical practices in biomedical research, including the use of animal models. As concerns over animal welfare and environmental sustainability increase, researchers and regulatory agencies are seeking alternatives to traditional animal models and promoting the development of more ethical and environmentally friendly research methods. In response to this trend, there is a growing interest in the development of alternative model systems such as organoids, cell cultures, and computational models. While these alternatives may not completely replace mice models, they offer complementary approaches and reduce the reliance on animal experimentation. This trend towards sustainability and ethical research practices is influencing the development of mice models with reduced environmental impact and improved animal welfare standards, thereby shaping the future direction of the mice model market. Leading Companies focusing on Expansion into Precision Medicine Applications, Integration with Artificial Intelligence and Big Data Analytics, Emergence of Organ-on-Chip and Microfluidic Technologies, and others to boost market shares in the industry.
The mice model market is integral to biomedical research, providing researchers with invaluable tools for studying human diseases and advancing therapeutic interventions. Dominated by key players like Charles River Laboratories and The Jackson Laboratory, this market offers a wide range of mice models tailored to specific research needs, from genetically engineered to immunodeficient strains. Technological advancements, including CRISPR-Cas9 gene editing, drive the development of increasingly precise models, while regulatory bodies ensure ethical animal use. With growing investments in research and the rise of precision medicine, the market is poised for continued growth, augmented by emerging technologies such as organ-on-chip platforms and AI-driven analytics, which promise to reshape biomedical research in the future.
The mice model market is witnessing significant growth due to its vital role across various research domains such as oncology, neurology, immunology, and drug discovery. Mice models serve as indispensable tools for investigating human diseases, evaluating therapeutic strategies, and understanding biological processes. This surge in demand is amplified by advancements in genetic engineering, facilitating the creation of more precise models mirroring human physiology and pathology. Moreover, the growing focus on personalized medicine and targeted therapies has further propelled the need for mice models capable of replicating individual patient characteristics and responses accurately. Consequently, the mice model market is poised for sustained expansion, driven by ongoing research efforts and the pursuit of innovative solutions to tackle complex biomedical challenges.
The burgeoning focus on personalized medicine is significantly propelling the demand for mice models in biomedical research. This specialized approach to healthcare, which tailors medical interventions according to individual patient's genetic makeup, lifestyle, and environmental factors, underscores the necessity for highly accurate disease models that faithfully replicate the intricacies of human biology. Among these models, genetically modified mice strains hold particular importance, playing a pivotal role in assessing individual drug responses, pinpointing biomarkers, and formulating precise therapeutic approaches. Through the development of mice models that closely mirror human genetic diversity and disease susceptibility, researchers can glean invaluable insights into disease mechanisms and conduct targeted trials of personalized treatments in preclinical settings. With the continued evolution and adoption of personalized medicine within the healthcare landscape, there is a foreseen surge in demand for specialized mice models that facilitate seamless translation of research findings from laboratory experimentation to clinical application, thus fueling the expansion of the mice model market.
The mice model market is witnessing significant growth, largely fueled by its expanding role in immuno-oncology research. As immuno-oncology emerges as a promising avenue in cancer therapy, researchers are increasingly turning to mice models to delve into the intricate interplay between tumors and the immune system. These models serve as indispensable tools for assessing novel immunotherapies, probing immune checkpoint inhibitors, and predicting treatment outcomes in patients. With the escalating demand for precise preclinical models in immuno-oncology, the mice model market is poised for further expansion. This growth is underpinned by the necessity for specialized models capable of faithfully reproducing the complex dynamics of the tumor microenvironment and immune response.
The Global Mice Model Market is analyzed across Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases, and others. Oncology is poised to register the fastest growth. The oncology mice model market is integral to cancer research and drug development, facilitating the study of tumor biology, treatment responses, and therapeutic interventions. These models enable researchers to investigate tumor heterogeneity, genetic mutations, and the tumor microenvironment, while also serving as essential tools for evaluating anticancer drugs and exploring novel treatment modalities like immunotherapy and targeted therapy. With the growing emphasis on personalized medicine, the demand for sophisticated and clinically relevant mice models in oncology research is expected to fuel further growth in this market.
The Global Mice Model Market is analyzed across various technologies including CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, and others. Of these, CRISPR/Cas9 held a significant market share in 2024. The CRISPR/Cas9 mice model market is rapidly expanding due to the revolutionary CRISPR/Cas9 gene editing technology, enabling precise and efficient genome modifications in mice. This technology has transformed biomedical research by facilitating the creation of genetically engineered mice models for studying gene function, modeling human diseases, and evaluating potential therapeutics. With growing demand across various research areas, including oncology, neurology, immunology, metabolic diseases, and cardiovascular diseases, the CRISPR/Cas9 mice model market is poised for substantial growth.
By Model Type and Service
By Technology
By Therapeutic Area
By Application
By End User
By Region
*List not exhaustive
Mice Model Market Outlook 2024
1 Market Overview
1.1 Introduction to the Mice Model Market
1.2 Scope of the Study
1.3 Research Objective
1.3.1 Key Market Scope and Segments
1.3.2 Players Covered
1.3.3 Years Considered
2 Executive Summary
2.1 2024 Mice Model Industry- Market Statistics
3 Market Dynamics
3.1 Market Drivers
3.2 Market Challenges
3.3 Market Opportunities
3.4 Market Trends
4 Market Factor Analysis
4.1 Porter’s Five Forces
4.2 Market Entropy
4.2.1 Global Mice Model Market Companies with Area Served
4.2.2 Products Offerings Global Mice Model Market
5 Recession Impact Analysis and Outlook Scenarios
5.1.1 Recission Impact Analysis
5.1.2 Market Growth Scenario- Base Case
5.1.3 Market Growth Scenario- Reference Case
5.1.4 Market Growth Scenario- High Case
6 Global Mice Model Market Trends
6.1 Global Mice Model Revenue (USD Million) and CAGR (%) by Type (2018-2032)
6.2 Global Mice Model Revenue (USD Million) and CAGR (%) by Applications (2018-2032)
6.3 Global Mice Model Revenue (USD Million) and CAGR (%) by Regions (2018-2032)
7 Global Mice Model Market Revenue (USD Million) by Type, and Applications (2018-2023)
7.1 Global Mice Model Revenue (USD Million) by Type (2018-2023)
7.1.1 Global Mice Model Revenue (USD Million), Market Share (%) by Type (2018-2023)
7.2 Global Mice Model Revenue (USD Million) by Applications (2018-2023)
7.2.1 Global Mice Model Revenue (USD Million), Market Share (%) by Applications (2018-2023)
8 Global Mice Model Development Regional Status and Outlook
8.1 Global Mice Model Revenue (USD Million) By Regions (2018-2023)
8.2 North America Mice Model Revenue (USD Million) by Type, and Application (2018-2023)
8.2.1 North America Mice Model Revenue (USD Million) by Country (2018-2023)
8.2.2 North America Mice Model Revenue (USD Million) by Type (2018-2023)
8.2.3 North America Mice Model Revenue (USD Million) by Applications (2018-2023)
8.3 Europe Mice Model Revenue (USD Million), by Type, and Applications (USD Million) (2018-2023)
8.3.1 Europe Mice Model Revenue (USD Million), by Country (2018-2023)
8.3.2 Europe Mice Model Revenue (USD Million) by Type (2018-2023)
8.3.3 Europe Mice Model Revenue (USD Million) by Applications (2018-2023)
8.4 Asia Pacific Mice Model Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2023)
8.4.1 Asia Pacific Mice Model Revenue (USD Million) by Country (2018-2023)
8.4.2 Asia Pacific Mice Model Revenue (USD Million) by Type (2018-2023)
8.4.3 Asia Pacific Mice Model Revenue (USD Million) by Applications (2018-2023)
8.5 South America Mice Model Revenue (USD Million), by Type, and Applications (2018-2023)
8.5.1 South America Mice Model Revenue (USD Million), by Country (2018-2023)
8.5.2 South America Mice Model Revenue (USD Million) by Type (2018-2023)
8.5.3 South America Mice Model Revenue (USD Million) by Applications (2018-2023)
8.6 Middle East and Africa Mice Model Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2023)
8.6.1 Middle East and Africa Mice Model Revenue (USD Million) by Country (2018-2023)
8.6.2 Middle East and Africa Mice Model Revenue (USD Million) by Type (2018-2023)
8.6.3 Middle East and Africa Mice Model Revenue (USD Million) by Applications (2018-2023)
9 Company Profiles
10 Global Mice Model Market Revenue (USD Million), by Type, and Applications (2024-2032)
10.1 Global Mice Model Revenue (USD Million) and Market Share (%) by Type (2024-2032)
10.1.1 Global Mice Model Revenue (USD Million), and Market Share (%) by Type (2024-2032)
10.2 Global Mice Model Revenue (USD Million) and Market Share (%) by Applications (2024-2032)
10.2.1 Global Mice Model Revenue (USD Million), and Market Share (%) by Applications (2024-2032)
11 Global Mice Model Development Regional Status and Outlook Forecast
11.1 Global Mice Model Revenue (USD Million) By Regions (2024-2032)
11.2 North America Mice Model Revenue (USD Million) by Type, and Applications (2024-2032)
11.2.1 North America Mice Model Revenue (USD) Million by Country (2024-2032)
11.2.2 North America Mice Model Revenue (USD Million), by Type (2024-2032)
11.2.3 North America Mice Model Revenue (USD Million), Market Share (%) by Applications (2024-2032)
11.3 Europe Mice Model Revenue (USD Million), by Type, and Applications (2024-2032)
11.3.1 Europe Mice Model Revenue (USD Million), by Country (2024-2032)
11.3.2 Europe Mice Model Revenue (USD Million), by Type (2024-2032)
11.3.3 Europe Mice Model Revenue (USD Million), by Applications (2024-2032)
11.4 Asia Pacific Mice Model Revenue (USD Million) by Type, and Applications (2024-2032)
11.4.1 Asia Pacific Mice Model Revenue (USD Million), by Country (2024-2032)
11.4.2 Asia Pacific Mice Model Revenue (USD Million), by Type (2024-2032)
11.4.3 Asia Pacific Mice Model Revenue (USD Million), by Applications (2024-2032)
11.5 South America Mice Model Revenue (USD Million), by Type, and Applications (2024-2032)
11.5.1 South America Mice Model Revenue (USD Million), by Country (2024-2032)
11.5.2 South America Mice Model Revenue (USD Million), by Type (2024-2032)
11.5.3 South America Mice Model Revenue (USD Million), by Applications (2024-2032)
11.6 Middle East and Africa Mice Model Revenue (USD Million), by Type, and Applications (2024-2032)
11.6.1 Middle East and Africa Mice Model Revenue (USD Million), by region (2024-2032)
11.6.2 Middle East and Africa Mice Model Revenue (USD Million), by Type (2024-2032)
11.6.3 Middle East and Africa Mice Model Revenue (USD Million), by Applications (2024-2032)
12 Methodology and Data Sources
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Sources
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
List of Tables
Table 1 Market Segmentation Analysis
Table 2 Global Mice Model Market Companies with Areas Served
Table 3 Products Offerings Global Mice Model Market
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Mice Model Revenue (USD Million) And CAGR (%) By Type (2018-2032)
Table 8 Global Mice Model Revenue (USD Million) And CAGR (%) By Applications (2018-2032)
Table 9 Global Mice Model Revenue (USD Million) And CAGR (%) By Regions (2018-2032)
Table 10 Global Mice Model Revenue (USD Million) By Type (2018-2023)
Table 11 Global Mice Model Revenue Market Share (%) By Type (2018-2023)
Table 12 Global Mice Model Revenue (USD Million) By Applications (2018-2023)
Table 13 Global Mice Model Revenue Market Share (%) By Applications (2018-2023)
Table 14 Global Mice Model Market Revenue (USD Million) By Regions (2018-2023)
Table 15 Global Mice Model Market Share (%) By Regions (2018-2023)
Table 16 North America Mice Model Revenue (USD Million) By Country (2018-2023)
Table 17 North America Mice Model Revenue (USD Million) By Type (2018-2023)
Table 18 North America Mice Model Revenue (USD Million) By Applications (2018-2023)
Table 19 Europe Mice Model Revenue (USD Million) By Country (2018-2023)
Table 20 Europe Mice Model Revenue (USD Million) By Type (2018-2023)
Table 21 Europe Mice Model Revenue (USD Million) By Applications (2018-2023)
Table 22 Asia Pacific Mice Model Revenue (USD Million) By Country (2018-2023)
Table 23 Asia Pacific Mice Model Revenue (USD Million) By Type (2018-2023)
Table 24 Asia Pacific Mice Model Revenue (USD Million) By Applications (2018-2023)
Table 25 South America Mice Model Revenue (USD Million) By Country (2018-2023)
Table 26 South America Mice Model Revenue (USD Million) By Type (2018-2023)
Table 27 South America Mice Model Revenue (USD Million) By Applications (2018-2023)
Table 28 Middle East and Africa Mice Model Revenue (USD Million) By Region (2018-2023)
Table 29 Middle East and Africa Mice Model Revenue (USD Million) By Type (2018-2023)
Table 30 Middle East and Africa Mice Model Revenue (USD Million) By Applications (2018-2023)
Table 31 Financial Analysis
Table 32 Global Mice Model Revenue (USD Million) By Type (2024-2032)
Table 33 Global Mice Model Revenue Market Share (%) By Type (2024-2032)
Table 34 Global Mice Model Revenue (USD Million) By Applications (2024-2032)
Table 35 Global Mice Model Revenue Market Share (%) By Applications (2024-2032)
Table 36 Global Mice Model Market Revenue (USD Million), And Revenue (USD Million) By Regions (2024-2032)
Table 37 North America Mice Model Revenue (USD)By Country (2024-2032)
Table 38 North America Mice Model Revenue (USD Million) By Type (2024-2032)
Table 39 North America Mice Model Revenue (USD Million) By Applications (2024-2032)
Table 40 Europe Mice Model Revenue (USD Million) By Country (2024-2032)
Table 41 Europe Mice Model Revenue (USD Million) By Type (2024-2032)
Table 42 Europe Mice Model Revenue (USD Million) By Applications (2024-2032)
Table 43 Asia Pacific Mice Model Revenue (USD Million) By Country (2024-2032)
Table 44 Asia Pacific Mice Model Revenue (USD Million) By Type (2024-2032)
Table 45 Asia Pacific Mice Model Revenue (USD Million) By Applications (2024-2032)
Table 46 South America Mice Model Revenue (USD Million) By Country (2024-2032)
Table 47 South America Mice Model Revenue (USD Million) By Type (2024-2032)
Table 48 South America Mice Model Revenue (USD Million) By Applications (2024-2032)
Table 49 Middle East and Africa Mice Model Revenue (USD Million) By Region (2024-2032)
Table 50 Middle East and Africa Mice Model Revenue (USD Million) By Region (2024-2032)
Table 51 Middle East and Africa Mice Model Revenue (USD Million) By Type (2024-2032)
Table 52 Middle East and Africa Mice Model Revenue (USD Million) By Applications (2024-2032)
Table 53 Research Programs/Design for This Report
Table 54 Key Data Information from Secondary Sources
Table 55 Key Data Information from Primary Sources
List of Figures
Figure 1 Market Scope
Figure 2 Porter’s Five Forces
Figure 3 Global Mice Model Revenue (USD Million) By Type (2018-2023)
Figure 4 Global Mice Model Revenue Market Share (%) By Type (2023)
Figure 5 Global Mice Model Revenue (USD Million) By Applications (2018-2023)
Figure 6 Global Mice Model Revenue Market Share (%) By Applications (2023)
Figure 7 Global Mice Model Market Revenue (USD Million) By Regions (2018-2023)
Figure 8 Global Mice Model Market Share (%) By Regions (2023)
Figure 9 North America Mice Model Revenue (USD Million) By Country (2018-2023)
Figure 10 North America Mice Model Revenue (USD Million) By Type (2018-2023)
Figure 11 North America Mice Model Revenue (USD Million) By Applications (2018-2023)
Figure 12 Europe Mice Model Revenue (USD Million) By Country (2018-2023)
Figure 13 Europe Mice Model Revenue (USD Million) By Type (2018-2023)
Figure 14 Europe Mice Model Revenue (USD Million) By Applications (2018-2023)
Figure 15 Asia Pacific Mice Model Revenue (USD Million) By Country (2018-2023)
Figure 16 Asia Pacific Mice Model Revenue (USD Million) By Type (2018-2023)
Figure 17 Asia Pacific Mice Model Revenue (USD Million) By Applications (2018-2023)
Figure 18 South America Mice Model Revenue (USD Million) By Country (2018-2023)
Figure 19 South America Mice Model Revenue (USD Million) By Type (2018-2023)
Figure 20 South America Mice Model Revenue (USD Million) By Applications (2018-2023)
Figure 21 Middle East and Africa Mice Model Revenue (USD Million) By Region (2018-2023)
Figure 22 Middle East and Africa Mice Model Revenue (USD Million) By Type (2018-2023)
Figure 23 Middle East and Africa Mice Model Revenue (USD Million) By Applications (2018-2023)
Figure 24 Global Mice Model Revenue (USD Million) By Type (2024-2032)
Figure 25 Global Mice Model Revenue Market Share (%) By Type (2030)
Figure 26 Global Mice Model Revenue (USD Million) By Applications (2024-2032)
Figure 27 Global Mice Model Revenue Market Share (%) By Applications (2030)
Figure 28 Global Mice Model Market Revenue (USD Million) By Regions (2024-2032)
Figure 29 North America Mice Model Revenue (USD Million) By Country (2024-2032)
Figure 30 North America Mice Model Revenue (USD Million) By Type (2024-2032)
Figure 31 North America Mice Model Revenue (USD Million) By Applications (2024-2032)
Figure 32 Europe Mice Model Revenue (USD Million) By Country (2024-2032)
Figure 33 Europe Mice Model Revenue (USD Million) By Type (2024-2032)
Figure 34 Europe Mice Model Revenue (USD Million) By Applications (2024-2032)
Figure 35 Asia Pacific Mice Model Revenue (USD Million) By Country (2024-2032)
Figure 36 Asia Pacific Mice Model Revenue (USD Million) By Type (2024-2032)
Figure 37 Asia Pacific Mice Model Revenue (USD Million) By Applications (2024-2032)
Figure 38 South America Mice Model Revenue (USD Million) By Country (2024-2032)
Figure 39 South America Mice Model Revenue (USD Million) By Type (2024-2032)
Figure 40 South America Mice Model Revenue (USD Million) By Applications (2024-2032)
Figure 41 Middle East and Africa Mice Model Revenue (USD Million) By Region (2024-2032)
Figure 42 Middle East and Africa Mice Model Revenue (USD Million) By Region (2024-2032)
Figure 43 Middle East and Africa Mice Model Revenue (USD Million) By Type (2024-2032)
Figure 44 Middle East and Africa Mice Model Revenue (USD Million) By Applications (2024-2032)
Figure 45 Bottom-Up and Top-Down Approaches for This Report
Figure 46 Data Triangulation
By Model Type and Service
By Technology
By Therapeutic Area
By Application
By End User
By Region
The global Mice Model Market is one of the lucrative growth markets, poised to register a 8.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Biocytogen, Charles River laboratories, Cyagen, Gempharmatech, Genoway, Harbour Biomed. Inotiv. Jsr corporation, Marshall bioresources, Ozgene pty ltd, . Shanghai Model Organisms Center Inc, Taconic Biosciences Inc, The jackson laboratory, Trans genic inc, Transcure bioservices,Â
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume